Statistical Sequential Experimentation: Preliminary Mixed Factorial Design, I-Optimal Mixture Design Then Finally Novel Design Space Expansion for Optimization of Tazarotene Cubosomes

References

• Singh Malik D, Mital N, Kaur G. Topical drug delivery systems: a patent review. Expert Opin Ther Pat. 2016;26(2):213–228. doi:10.1517/13543776.2016.1131267
   PubMed Web of Science ®Google Scholar
• Nene S, Shah S, Rangaraj N, Mehra NK, Singh PK, Srivastava S. Lipid based nanocarriers: a novel paradigm for topical antifungal therapy. J Drug Deliv Sci Technol. 2021;62:102397. doi:10.1016/J.JDDST.2021.102397
   Web of Science ®Google Scholar
• Castañeda-Reyes ED, Perea-Flores MDJ, Davila-Ortiz G, Lee Y, de Mejia EG. Development, characterization and use of liposomes as amphipathic transporters of bioactive compounds for melanoma treatment and reduction of skin inflammation: a review. Int J Nanomedicine. 2020;15:7627–7650. doi:10.2147/IJN.S263516
   PubMed Web of Science ®Google Scholar
• Goyal G, Garg T, Malik B, Chauhan G, Rath G, Goyal AK. Development and characterization of niosomal gel for topical delivery of benzoyl peroxide. Drug Deliv. 2015;22(8):1027–1042. doi:10.3109/10717544.2013.855277
   PubMed Web of Science ®Google Scholar
• Rahman SA, Abdelmalak NS, Badawi A, Elbayoumy T, Sabry N, El RA. Formulation of tretinoin-loaded topical proniosomes for treatment of acne: in-vitro characterization, skin irritation test and comparative clinical study. Drug Deliv. 2015;22(6):731–739. doi:10.3109/10717544.2014.896428
   PubMed Web of Science ®Google Scholar
• Abdelgawad R, Nasr M, Moftah NH, Hamza MY. Phospholipid membrane tubulation using ceramide doping “Cerosomes”: characterization and clinical application in psoriasis treatment. Eur J Pharm Sci. 2017;101:258–268. doi:10.1016/j.ejps.2017.02.030
   PubMed Web of Science ®Google Scholar
• Kang JH, Chon J, Il KY, et al. Preparation and evaluation of tacrolimus-loaded thermosensitive solid lipid nanoparticles for improved dermal distribution. Int J Nanomedicine. 2019;14:5381–5396. doi:10.2147/IJN.S215153
   PubMed Web of Science ®Google Scholar
• Gokce EH, Korkmaz E, Dellera E, Sandri G, Cristina Bonferoni M, Ozer O. Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications. Int J Nanomedicine. 2012;7:1841–1850. doi:10.2147/IJN.S29710
   PubMed Web of Science ®Google Scholar
• Zanela da silva Marques T, Santos-Oliveira R, De Siqueira LBDO, et al. Development and characterization of a nanoemulsion containing propranolol for topical delivery. Int J Nanomedicine. 2018;13:2827–2837. doi:10.2147/IJN.S164404
   PubMed Web of Science ®Google Scholar
• Patel MR, Patel RB, Parikh JR, Patel BG. Formulation consideration and skin retention study of microemulsion containing tazarotene for targeted therapy of acne. J Pharm Investig. 2016;46(1):55–66. doi:10.1007/s40005-015-0213-0
   Google Scholar
• Nasr M, Abdel-Hamid S. Optimizing the dermal accumulation of a tazarotene microemulsion using skin deposition modeling. Drug Dev Ind Pharm. 2016;42(4):636–643. doi:10.3109/03639045.2015.1062512
   PubMed Web of Science ®Google Scholar
• Avantika D, Raj SD, Vinay P, Singh AM, Pravin K. Cubosomes: a novel carrier for transdermal drug delivery. J drug Deliv Ther. 2020;10(1):123–130. doi:10.22270/jddt.v10i1.3814
   Google Scholar
• El-enin HA, Al-shanbari AH. Nanostructured liquid crystalline formulation as a remarkable new drug delivery system of anti-epileptic drugs for treating children patients. Saudi Pharm J. 2018;26(6):790–800. doi:10.1016/j.jsps.2018.04.004
   PubMed Web of Science ®Google Scholar
• Chong JYT, Mulet X, Boyd BJ, Drummond CJ. Steric stabilizers for cubic phase lyotropic liquid crystal nanodispersions (Cubosomes). Adv Planar Lipid Bilayers Liposomes. 2015;21:131–187. doi:10.1016/bs.adplan.2014.11.001
   Google Scholar
• Eldeeb AE, Salah S, Ghorab M. Formulation and evaluation of cubosomes drug delivery system for treatment of glaucoma: ex-vivo permeation and in-vivo pharmacodynamic study. J Drug Deliv Sci Technol. 2019;52:236–247. doi:10.1016/j.jddst.2019.04.036
   Web of Science ®Google Scholar
• Younes NF, Abdel-halim SA, Elassasy AI. Corneal targeted Sertaconazole nitrate loaded cubosomes: preparation, statistical optimization, in vitro characterization, ex vivo permeation and in vivo studies. Int J Pharm. 2018;553(1–2):386–397. doi:10.1016/j.ijpharm.2018.10.057
   PubMed Web of Science ®Google Scholar
• Van De Kerkhof PCM. Update on retinoid therapy of psoriasis in: an update on the use of retinoids in dermatology. Dermatol Ther. 2006;19(5):252–263. doi:10.1111/j.1529-8019.2006.00082.x
   PubMed Web of Science ®Google Scholar
• Trials P, Shalita AR, Berson DS, et al. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials. Clin Ther. 2004;26(11):1865–1873. doi:10.1016/j.clinthera.2004.11.012
   PubMed Web of Science ®Google Scholar
• Gregoriou S, Kritsotaki E, Katoulis A, Rigopoulos D. Use of tazarotene foam for the treatment of acne vulgaris. Clin Cosmet Investig Dermatol. 2014;7:165–170. doi:10.2147/CCID.S37327
   PubMedGoogle Scholar
• Chiricozzi A, Chimenti S. Effective topical agents and emerging perspectives in the treatment of psoriasis. Expert Rev Dermatol. 2012;7(3):283–293. doi:10.1586/edm.12.18
   Google Scholar
• Makky A, Mohamed M, Abdellatif M. Liposomal gels as carriers for safer topical delivery of Tazarotene. J Pharm Res Opin. 2014;3(12):82–90.
   Google Scholar
• Prasad V, Chaurasia S. Performance evaluation of non-ionic surfactant based tazarotene encapsulated proniosomal gel for the treatment of psoriasis. Mater Sci Eng C. 2017;79:168–176. doi:10.1016/j.msec.2017.05.036
   PubMed Web of Science ®Google Scholar
• Patel MR, Patel RB, Parikh JR, Patel BG. Novel microemulsion-based gel formulation of tazarotene for therapy of acne. Pharm Dev Technol. 2015;21(8):1–12. doi:10.3109/10837450.2015.1081610
   Web of Science ®Google Scholar
• Elmowafy E, El-Gogary RI, Ragai MH, Nasr M. Novel antipsoriatic fluidized spanlastic nanovesicles: in vitro physicochemical characterization, ex vivo cutaneous retention and exploratory clinical therapeutic efficacy. Int J Pharm. 2019;568:118556. doi:10.1016/j.ijpharm.2019.118556
   PubMed Web of Science ®Google Scholar
• Liu P, Yang X, Han J, et al. Tazarotene-loaded PLGA nanoparticles potentiate deep tissue pressure injury healing via VEGF-Notch signaling. Mater Sci Eng C. 2020;114:111027. doi:10.1016/j.msec.2020.111027
   PubMed Web of Science ®Google Scholar
• Aggarwal G, Nagpal M. Development and comparison of nanosponge and niosome based gel for the topical delivery of Tazarotene. Pharmaceut nanotechnol. 2016;4(3):213–228. doi:10.2174/221173850466616080415
   PubMedGoogle Scholar
• Erol İ, Üstündağ Okur N, Orak D, Sipahi H, Aydın A, Özer Ö. Tazarotene-loaded in situ gels for potential management of psoriasis: biocompatibility, anti-inflammatory and analgesic effect. Pharm Dev Technol. 2020;25(8):909–918. doi:10.1080/10837450.2020.1765180
   PubMed Web of Science ®Google Scholar
• Montgomery DC. Design and Analysis of Experiments Eighth Edition. 8th Montgomery DC, eds. New York, USA: John Wiley & Sons, Inc.; 2013
   Google Scholar
• Habib BA, Abd El-Samiae AS, El-Houssieny BM, Tag R. Formulation, characterization, optimization, and in-vivo performance of febuxostat self-nano-emulsifying system loaded sublingual films. Drug Deliv. 2021;28(1):1321–1333. doi:10.1080/10717544.2021.1927247
   PubMed Web of Science ®Google Scholar
• Fahmy AM, El-Setouhy DA, Habib BA, Tayel SA. Enhancement of transdermal delivery of haloperidol via spanlastic dispersions: entrapment efficiency vs. particle size. AAPS PharmSciTech. 2019;20(3):1–13. doi:10.1208/s12249-019-1306-2
   Web of Science ®Google Scholar
• Nageeb El-Helaly S, Habib BA, Abd El-Rahman MK. Resolution V fractional factorial design for screening of factors affecting weakly basic drugs liposomal systems. Eur J Pharm Sci. 2018;119:249–258. doi:10.1016/j.ejps.2018.04.028
   PubMed Web of Science ®Google Scholar
• Said M, Elsayed I, Aboelwafa AA, Elshafeey AH. A novel concept of overcoming the skin barrier using augmented liquid nanocrystals: box-Behnken optimization, ex vivo and in vivo evaluation. Colloids Surf B Biointerfaces. 2018;170:258–265. doi:10.1016/j.colsurfb.2018.06.025
   PubMed Web of Science ®Google Scholar
• Naguib SS, Hathout RM, Mansour S. Optimizing novel penetration enhancing hybridized vesicles for augmenting the in-vivo effect of an anti-glaucoma drug. Drug Deliv. 2017;24(1):99–108. doi:10.1080/10717544.2016.1233588
   PubMed Web of Science ®Google Scholar
• Habib BA, Aboughaly MHH. Combined mixture-process variable approach: a suitable statistical tool for nanovesicular systems optimization. Expert Opin Drug Deliv. 2016;13(6):777–788. doi:10.1517/17425247.2016.1166202
   PubMed Web of Science ®Google Scholar
• Buruk Sahin Y, Aktar Demirtaş E, Burnak N. Mixture design: a review of recent applications in the food industry. J Eng Sci. 2016;22(4):297–304. doi:10.5505/pajes.2015.98598
   Google Scholar
• Bezener M. Strategies for sequential experimentation; 2020. Available from: https://www.statease.com/webinars/strategies-sequentialexperimentation. Accessed February 3, 2022.
   Google Scholar
• Siekmann B, Bunjes H, Koch MHJ, Westesen K. Preparation and structural investigations of colloidal dispersions prepared from cubic monoglyceride – water phases. Int J Pharm. 2002;244(1–2):33–43. doi:10.1016/s0378-5173(02)00298-3
   PubMed Web of Science ®Google Scholar
• Fouda NH, Abdelrehim RT, Hegazy DA, Habib BA. Sustained ocular delivery of dorzolamide-HCL via proniosomal gel formulation: in-vitro characterization, statistical optimization, and in-vivo pharmacodynamic evaluation in rabbits. Drug Deliv. 2018;25(1):1340–1349. doi:10.1080/10717544.2018.1477861
   PubMed Web of Science ®Google Scholar
• Kapoor K, Pandit V, Nagaich U. Development and characterization of sustained release methotrexate loaded cubosomes for topical delivery in rheumatoid arthritis. Int J Appl Pharm. 2020;12(3):33–39. doi:10.22159/ijap.2020v12i3.36863
   PubMedGoogle Scholar
• Wu H, Li J, Zhang Q, et al. A novel small Odorranalectin-bearing cubosomes: preparation, brain delivery and pharmacodynamic study on amyloid-β 25–35-treated rats following intranasal administration. Eur J Pharm Biopharm. 2012;80(2):368–378. doi:10.1016/j.ejpb.2011.10.012
   PubMed Web of Science ®Google Scholar
• Al-Mahallawi AM, Khowessah OM, Shoukri RA. Nano-transfersomal ciprofloxacin loaded vesicles for non-invasive trans-tympanic ototopical delivery: in-vitro optimization, ex-vivo permeation studies, and in-vivo assessment. Int J Pharm. 2014;472(1–2):304–314. doi:10.1016/j.ijpharm.2014.06.041
   PubMed Web of Science ®Google Scholar
• Radwan SAA, El-Maadawy WH, Yousry C, Elmeshad AN, Shoukri RA. Zein/phospholipid composite nanoparticles for successful delivery of gallic acid into ahscs: influence of size, surface charge, and vitamin a coupling. Int J Nanomedicine. 2020;15:7995–8018. doi:10.2147/IJN.S270242
   PubMed Web of Science ®Google Scholar
• Patel MR, Patel RB, Parikh JR, Patel BG. HPTLC method for estimation of tazarotene in topical gel formulations and in vitro study. Anal Methods. 2010;2(3):275–281. doi:10.1039/b9ay00240e
   Web of Science ®Google Scholar
• Montenegro L, Panico AM, Ventimiglia A, Bonina FP. In vitro retinoic acid release and skin permeation from different liposome formulations. Int J Pharm. 1996;133(1–2):89–96. doi:10.1016/0378-5173(95)04422-1
   Web of Science ®Google Scholar
• Derringer G, Suich R. Simultaneous optimization of several response variables. J Qual Technol. 1980;12(4):214–219. doi:10.1080/00224065.1980.11980968
   Web of Science ®Google Scholar
• El Taweel MM, Aboul-einien MH, Kassem MA, Elkasabgy NA. Intranasal zolmitriptan-loaded bilosomes with extended nasal mucociliary transit time for direct nose to brain delivery. Pharmaceutics. 2021;13(11):1828. doi:10.3390/pharmaceutics13111828
   PubMed Web of Science ®Google Scholar
• Galisteo-González F, Molina-Bolívar JA. Systematic study on the preparation of BSA nanoparticles. Colloids Surf B Biointerfaces. 2014;123:286–292. doi:10.1016/j.colsurfb.2014.09.028
   PubMed Web of Science ®Google Scholar
• Elgindy NA, Mehanna MM, Mohyeldin SM. Self-assembled nano-architecture liquid crystalline particles as a promising carrier for progesterone transdermal delivery. Int J Pharm. 2016;501(1–2):167–179. doi:10.1016/j.ijpharm.2016.01.049
   PubMed Web of Science ®Google Scholar
• Mohyeldin SM, Mehanna MM, Elgindy NA. Superiority of liquid crystalline cubic nanocarriers as hormonal transdermal vehicle: comparative human skin permeation-supported evidence. Expert Opin Drug Deliv. 2016;13(8):1049–1064. doi:10.1080/17425247.2016.1182490
   PubMed Web of Science ®Google Scholar
• Vogel R, Pal AK, Jambhrunkar S, et al. High-resolution single particle zeta potential characterisation of biological nanoparticles using tunable resistive pulse sensing. Sci Rep. 2017;7(1):1–13. doi:10.1038/s41598-017-14981-x
   PubMed Web of Science ®Google Scholar
• Bergmeir C, Hyndman RJ, Benítez JM. Bagging exponential smoothing methods using STL decomposition and Box-Cox transformation. Int J Forecast. 2016;32(2):303–312. doi:10.1016/j.ijforecast.2015.07.002
   Web of Science ®Google Scholar
• Habib BA, Sayed S, Elsayed GM. Enhanced transdermal delivery of ondansetron using nanovesicular systems: fabrication, characterization, optimization and ex-vivo permeation study-Box-Cox transformation practical example. Eur J Pharm Sci. 2018;115:352–361. doi:10.1016/j.ejps.2018.01.044
   PubMed Web of Science ®Google Scholar
• Lv Y, He H, Qi J, et al. Visual validation of the measurement of entrapment efficiency of drug nanocarriers. Int J Pharm. 2018;547(1–2):395–403. doi:10.1016/j.ijpharm.2018.06.025
   PubMed Web of Science ®Google Scholar
• Agrawal U, Gupta M, Vyas SP. Capsaicin delivery into the skin with lipidic nanoparticles for the treatment of psoriasis. Artif Cells Nanomed Biotechnol. 2015;43(1):33–39. doi:10.3109/21691401.2013.832683
   PubMed Web of Science ®Google Scholar
• Liu J, Hu W, Chen H, Ni Q, Xu H, Yang X. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int J Pharm. 2007;328(2):191–195. doi:10.1016/j.ijpharm.2006.08.007
   PubMed Web of Science ®Google Scholar
• Aboud HM, Hassan AH, Ali AA, Abdel-Razik ARH. Novel in situ gelling vaginal sponges of sildenafil citrate-based cubosomes for uterine targeting. Drug Deliv. 2018;25(1):1328–1339. doi:10.1080/10717544.2018.1477858
   PubMed Web of Science ®Google Scholar
• Abdelrahman FE, Elsayed I, Gad MK, Badr A, Mohamed MI. Investigating the cubosomal ability for transnasal brain targeting: in vitro optimization, ex vivo permeation and in vivo biodistribution. Int J Pharm. 2015;490(1–2):281–291. doi:10.1016/j.ijpharm.2015.05.064
   PubMed Web of Science ®Google Scholar
• Danaei M, Dehghankhold M, Ataei S, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018;10(2):1–17. doi:10.3390/pharmaceutics10020057
   Web of Science ®Google Scholar
• Bahari LAS, Hamishehkar H. The impact of variables on particle size of solid lipid nanoparticles and nanostructured lipid carriers; A comparative literature review. Adv Pharm Bull. 2016;6(2):143–151. doi:10.15171/apb.2016.021
   PubMed Web of Science ®Google Scholar
• Thakur R, Anwer MK, Shams MS, et al. Proniosomal transdermal therapeutic system of losartan potassium: development and pharmacokinetic evaluation. J Drug Target. 2009;17(6):442–449. doi:10.1080/10611860902963039
   PubMed Web of Science ®Google Scholar
• Esposito E, Eblovi N, Rasi S, et al. Lipid-based supramolecular systems for topical application: a preformulatory study. AAPS PharmSci. 2003;5(4):1–15. doi:10.1208/ps050430
   Google Scholar
• Weng J, Tong HHY, Chow SF. In vitro release study of the polymeric drug nanoparticles: development and validation of a novel method. Pharmaceutics. 2020;12(8):1–18. doi:10.3390/pharmaceutics12080732
   Web of Science ®Google Scholar
• D’Souza S. A review of in vitro drug release test methods for nano-sized dosage forms. Adv Pharm. 2014;2014:1–12. doi:10.1155/2014/304757
   Google Scholar
• Rapalli VK, Kaul V, Waghule T, et al. Curcumin loaded nanostructured lipid carriers for enhanced skin retained topical delivery: optimization, scale-up, in-vitro characterization and assessment of ex-vivo skin deposition. Eur J Pharm Sci. 2020;152:105438. doi:10.1016/j.ejps.2020.105438
   PubMed Web of Science ®Google Scholar
• Omar S, Ismail A, Hassanin K, Hamdy S. Formulation and evaluation of cubosomes as skin retentive system for topical delivery of clotrimazole. J Adv Pharm Res. 2019;3(2):68–82. doi:10.21608/aprh.2019.9839.1079
   Google Scholar
• Sherif S, Bendas ER, Badawy S. The clinical efficacy of cosmeceutical application of liquid crystalline nanostructured dispersions of alpha lipoic acid as anti-wrinkle. Eur J Pharm Biopharm. 2014;86(2):251–259. doi:10.1016/j.ejpb.2013.09.008
   PubMed Web of Science ®Google Scholar
• Morsi NM, Abdelbary GA, Ahmed MA. Silver sulfadiazine based cubosome hydrogels for topical treatment of burns: development and in vitro/in vivo characterization. Eur J Pharm Biopharm. 2014;86(2):178–189. doi:10.1016/j.ejpb.2013.04.018
   PubMed Web of Science ®Google Scholar